ONC
Price
$325.77
Change
-$2.94 (-0.89%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
38.86B
41 days until earnings call
ZLAB
Price
$31.62
Change
-$0.01 (-0.03%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
3.61B
46 days until earnings call
Interact to see
Advertisement

ONC vs ZLAB

Header iconONC vs ZLAB Comparison
Open Charts ONC vs ZLABBanner chart's image
BeOne Medicines
Price$325.77
Change-$2.94 (-0.89%)
Volume$2.24K
Capitalization38.86B
Zai Lab
Price$31.62
Change-$0.01 (-0.03%)
Volume$2.9K
Capitalization3.61B
ONC vs ZLAB Comparison Chart in %
Loading...
ONC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZLAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ONC vs. ZLAB commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ONC is a Buy and ZLAB is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (ONC: $328.71 vs. ZLAB: $31.63)
Brand notoriety: ONC and ZLAB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ONC: 71% vs. ZLAB: 44%
Market capitalization -- ONC: $38.86B vs. ZLAB: $3.61B
ONC [@Biotechnology] is valued at $38.86B. ZLAB’s [@Biotechnology] market capitalization is $3.61B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ONC’s FA Score shows that 0 FA rating(s) are green whileZLAB’s FA Score has 0 green FA rating(s).

  • ONC’s FA Score: 0 green, 5 red.
  • ZLAB’s FA Score: 0 green, 5 red.
According to our system of comparison, both ONC and ZLAB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ONC’s TA Score shows that 2 TA indicator(s) are bullish while ZLAB’s TA Score has 4 bullish TA indicator(s).

  • ONC’s TA Score: 2 bullish, 6 bearish.
  • ZLAB’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ZLAB is a better buy in the short-term than ONC.

Price Growth

ONC (@Biotechnology) experienced а -4.14% price change this week, while ZLAB (@Biotechnology) price change was -4.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +9.02%, and the average quarterly price growth was +51.46%.

Reported Earning Dates

ONC is expected to report earnings on Nov 06, 2025.

ZLAB is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ONC($38.9B) has a higher market cap than ZLAB($3.61B). ONC YTD gains are higher at: 77.960 vs. ZLAB (20.771). ONC has higher annual earnings (EBITDA): 89.3M vs. ZLAB (-195.33M). ONC has more cash in the bank: 2.76B vs. ZLAB (732M). ZLAB has less debt than ONC: ZLAB (191M) vs ONC (1.03B). ONC has higher revenues than ZLAB: ONC (4.56B) vs ZLAB (428M).
ONCZLABONC / ZLAB
Capitalization38.9B3.61B1,079%
EBITDA89.3M-195.33M-46%
Gain YTD77.96020.771375%
P/E RatioN/AN/A-
Revenue4.56B428M1,066%
Total Cash2.76B732M377%
Total Debt1.03B191M537%
FUNDAMENTALS RATINGS
ONC vs ZLAB: Fundamental Ratings
ONC
ZLAB
OUTLOOK RATING
1..100
1711
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
41
Fair valued
PROFIT vs RISK RATING
1..100
76100
SMR RATING
1..100
9397
PRICE GROWTH RATING
1..100
4259
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
9n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZLAB's Valuation (41) in the Biotechnology industry is in the same range as ONC (58). This means that ZLAB’s stock grew similarly to ONC’s over the last 12 months.

ONC's Profit vs Risk Rating (76) in the Biotechnology industry is in the same range as ZLAB (100). This means that ONC’s stock grew similarly to ZLAB’s over the last 12 months.

ONC's SMR Rating (93) in the Biotechnology industry is in the same range as ZLAB (97). This means that ONC’s stock grew similarly to ZLAB’s over the last 12 months.

ONC's Price Growth Rating (42) in the Biotechnology industry is in the same range as ZLAB (59). This means that ONC’s stock grew similarly to ZLAB’s over the last 12 months.

ONC's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ZLAB (100). This means that ONC’s stock grew similarly to ZLAB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ONCZLAB
RSI
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 9 days ago
76%
Bullish Trend 9 days ago
78%
Declines
ODDS (%)
Bearish Trend 30 days ago
77%
Bearish Trend 23 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
72%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
ONC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZLAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BTCZ3.120.21
+7.04%
T-Rex 2X Inverse Bitcoin Daily Target ETF
TFI45.54-0.03
-0.07%
SPDR Nuveen ICE Municipal Bond ETF
AFMC33.90-0.23
-0.69%
First Trust Active Factor Mid Cap ETF
UGE16.97-0.33
-1.91%
ProShares Ultra Consumer Staples
ETCG9.70-0.61
-5.90%
Grayscale Ethereum Classic Trust (ETC)

ONC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ONC has been loosely correlated with ZLAB. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ONC jumps, then ZLAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONC
1D Price
Change %
ONC100%
-0.34%
ZLAB - ONC
57%
Loosely correlated
-2.65%
MDGL - ONC
42%
Loosely correlated
-0.90%
WXXWY - ONC
37%
Loosely correlated
+1.92%
AXON - ONC
37%
Loosely correlated
+2.02%
LEGN - ONC
36%
Loosely correlated
-0.18%
More